Bristol-Myers drug fails liver cancer trial

Bristol-Myers drug fails liver cancer trial
The Bristol-Myers drug is an oral once-daily treatment that blocks receptors to VEGF, a protein involved in a lot of cancers, and also blocks enzymes known as FGFR tyrosine kinases that have been linked to cancer. The organization mentioned it will continue other …
Read a lot more on Chicago Tribune

New Hope In Kidney Illness Therapy
Scientists at UC Santa Barbara have demonstrated in the laboratory that a new drug is successful in treating a very widespread kidney illness –– though it will be a handful of years prior to it becomes available for clinical testing. The findings resulted from a …
Read much more on RedOrbit

Gene discovery could enhance therapy for acute myeloid leukemia
Scientists at Albert Einstein College of Medicine of Yeshiva University have made a discovery involving mice and humans that could imply that individuals with acute myeloid leukemia (AML), a uncommon and generally fatal cancer, are a step closer to new treatment …
Read a lot more on Health-related Xpress